4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-026230
Chief Operating Officer sold 5,401 shares at $40.00 ($216,040)
- Chief Operating Officer acquired 4,397 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GIVEN BRUCE D Chief Operating Officer | 2020-04-27 | Option exercise | +200 | $5.19 | $1,038 | 851,934 | D |
| GIVEN BRUCE D Chief Operating Officer | 2020-04-27 | Sale | −200 | $40.00 | $8,000 | 851,734 | D |
| GIVEN BRUCE D Chief Operating Officer | 2020-04-27 | Sale | −100 | $40.00 | $4,000 | 851,634 | D |
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Option exercise | +500 | $7.75 | $3,875 | 852,134 | D |
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Option exercise | +1,454 | $14.54 | $21,141 | 853,588 | D |
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Option exercise | +1,200 | $4.75 | $5,700 | 854,788 | D |
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Option exercise | +830 | $5.19 | $4,308 | 855,618 | D |
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Option exercise | +213 | $5.20 | $1,108 | 855,831 | D |
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Sale | −500 | $40.00 | $20,000 | 855,331 | D |
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Sale | −1,454 | $40.00 | $58,160 | 853,877 | D |
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Sale | −1,200 | $40.00 | $48,000 | 852,677 | D |
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Sale | −830 | $40.00 | $33,200 | 851,847 | D |
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Sale | −213 | $40.00 | $8,520 | 851,634 | D |
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Sale | −204 | $40.00 | $8,160 | 851,430 | D |
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Sale | −700 | $40.00 | $28,000 | 850,730 | D |
| Derivatives | |||||||
| GIVEN BRUCE D Chief Operating Officer | 2020-04-27 | Option exercise · Stock Option (right to buy) | −200 | 333,544 | D | ||
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Option exercise · Stock Option (right to buy) | −500 | 333,044 | D | ||
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Option exercise · Stock Option (right to buy) | −1,454 | 331,590 | D | ||
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Option exercise · Stock Option (right to buy) | −1,200 | 330,390 | D | ||
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Option exercise · Stock Option (right to buy) | −830 | 329,560 | D | ||
| GIVEN BRUCE D Chief Operating Officer | 2020-04-28 | Option exercise · Stock Option (right to buy) | −213 | 329,347 | D | ||
| Open-market sales · 5,401 sh · avg $40.00 · $216,040 | |||||||
Loading xslF345X03/doc4.xml…